Stimuli-Responsive Metal Complexes for Biomedical Applications
Ivanna Amarsy1, Sébastien Papot2, Gilles Gasser1
1Chimie ParisTech, PSL University, CNRS, Institute of Chemistry for Life and Health Sciences, Laboratory for Inorganic Chemical Biology, 75005, Paris, France.
Abstract:
Metal-based compounds have been widely used for biomedical applications. Their unique characteristics make them attractive for both therapeutic and diagnostic purposes. However, numerous issues including toxicity, poor aqueous solubility, and unfavorable biodistribution hamper their widespread use. To overcome these drawbacks, the concept of metal-based prodrugs emerged. This field is particularly developed for applications in oncology. More precisely, tumor-associated stimuli (e.g., pH variation, redox activity, enzyme overexpression, etc.) have been exploited to trigger the selective delivery of active metal-based drugs to the tumor site. The main advances in this area are discussed in this Review.
Insights
Metal-based prodrugs offer solutions to toxicity and delivery issues in cancer therapy. By exploiting tumor-specific triggers, these compounds enhance drug targeting and efficacy, improving biomedical applications.
Area of Science:
- Biomedical applications of metal-based compounds.
- Drug delivery systems.
- Oncology therapeutics.
Background:
- Metal compounds offer unique therapeutic and diagnostic potential.
- Challenges include toxicity, poor solubility, and biodistribution.
- Metal-based prodrugs address these limitations.
Purpose of the Study:
- To review advances in metal-based prodrugs for oncology.
- To highlight the exploitation of tumor-associated stimuli for targeted drug delivery.
Main Methods:
- Discussion of strategies for metal-based prodrug design.
- Analysis of tumor-specific triggers (pH, redox, enzymes).
- Review of recent developments in the field.
Main Results:
- Metal-based prodrugs demonstrate potential for targeted cancer therapy.
- Tumor-specific stimuli enable selective drug release.
- Overcoming limitations of traditional metal-based drugs.
Conclusions:
- Metal-based prodrugs represent a promising approach in oncology.
- Targeted delivery via tumor stimuli enhances therapeutic outcomes.
- Further development is crucial for clinical translation.
More Related Videos
11:04Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides
Published on: September 7, 2019
08:13Mitigation of Blood Borne Cell Attachment to Metal Implants through CD47-Derived Peptide Immobilization
Published on: December 3, 2020
Related Concept Videos
Metal-Ligand Bonds
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
Complexation Equilibria: Factors Influencing Stability of Complexes
Complexometric Titration: Ligands
Complexation Equilibria: The Chelate Effect
